Leidos Biomedical Research, Inc. (LBRI), a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research (FNLCR). FNLCR is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI). It is the only FFRDC dedicated to biomedical research. Through its status as an FFRDC, FNLCR provides NCI and others with a unique national resource to accelerate the development and delivery of effective preventive, diagnostic, and therapeutic products for cancer and AIDS.
The breadth of FNLCR’s activities spans the research and development spectrum, including investigator-initiated, hypothesis-driven research into cancer and AIDS; advanced technology programs focused on genetics and genomics, proteins and proteomics, imaging, nanotechnology, bioinformatics, and laboratory animal sciences; clinical operations in support of NCI and National Institute of Allergy and Infectious Diseases (NIAID)-sponsored clinical trials, as well as NCI drug discovery and development efforts; and management and operations of biopharmaceutical development and manufacturing programs under current Good Manufacturing Practice conditions for NCI and NIAID. Administrative, procurement, financial, safety, and facilities support is provided to these R&D activities through state-of-the-art business processes. LBRI has approximately 1,900 employees and manages an annual operating budget of approximately $450M.
For more information about Leidos Biomedical Research Inc., please visit our webpage at www.leidosbiomed.com.
The Partnership Development Office works to collaborative research agreements and other partnerships between Frederick National Laboratory for Cancer Research (FNLCR) scientists and external researchers in government, academia, industry, and the nonprofit research community. The goal of these collaborations is to advance science and accelerate progress against cancer and AIDS. Many of these partnerships aim at bridging the gap between late discovery and early development of diagnostics and therapeutics, by creating cross-cutting technology platforms, and by proposing new data standards.
This Director, Partnership Development Office (1) evaluating, developing, and managing strategic business opportunities, initiatives, partnerships, alliances and/or joint ventures, (2) coordinating resources and activities necessary to accomplish partnerships that span the Frederick National Laboratory for Cancer Research, (3) is the primary point of interface with the National Cancer Institute for coordinating partnerships between FNLCR and the extramural community, and (4) providing leadership in the planning, designing, due diligence, and implementation of strategic business objectives.
Ph.D./M.D. degree in a field related to cancer research or doctorate in Public Administration from an accredited college or university according to the Council for Higher Education Accreditation (CHEA)
Foreign degrees must be evaluated for U.S. equivalency
Eight (8) years of progressively responsible related experience
In-depth working knowledge of current practices within the Technology Transfer arena
Knowledge of and experience with Intellectual Property protection as it relates to Life Sciences
Previous contract, partnership or Strategic Alliance negotiation experience.
Excellent presentation skills, both written and verbal
Strong organizational skills with the ability to prioritize multiple tasks and projects
Experience working within a NCI-designated Cancer Center
Experience working at a national laboratory (FFRDC)
Experience with launching successful alliances involving several of the following Life Science capabilities: preclinical in vivo models, imaging, complex assay cascades, multi-lab experimental studies, biocomputing, and/or experimental clinical biomarkers
Experience with cancer research and medical oncology